Psychiatry & Neurology, Clinical Neurophysiology · Loma Linda, CA
NPI
1073750014
Since 2009
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
11370 Anderson St, Suite B-100
Loma Linda, CA, 92354
Phone (909) 558-2880
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
535 services
Medicare patients, 2024
248
Average age 58
Drug cost, 2024
$2.0M
4,083 prescriptions
Company payments, 2025
$214
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Firas Bannout was code 99214 (office e&m - established), 121 times for 86 patients. In total Firas Bannout billed 535 services in 34 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 121 | 86 | $77.73 | $9,405 |
| 95720 Neurologic | Facility | 98 | 37 | $162.93 | $16K |
| 95816 Neurologic | Facility | 44 | 43 | $43.01 | $1,893 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 27 | $12.80 | $435 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 11 | $62.84 | $2,011 |
| 99215 Office E&M - Established | Office | 29 | 23 | $126.24 | $3,661 |
| 95708 Neurologic | Office | 23 | 16 | $242.06 | $5,567 |
| 95718 Neurologic | Facility | 18 | 17 | $106.70 | $1,921 |
| 99213 Office E&M - Established | Office | 14 | 12 | $69.34 | $971 |
| 95700 Neurologic | Office | 12 | 12 | $219.51 | $2,634 |
| 95819 Neurologic | Facility | 11 | 11 | $41.05 | $452 |
By year: 2022 $47K for 461 services; 2023 $52K for 484 services; 2024 $51K for 535 services.
Medicare prescription drug claims, 2024
In 2024, the drug Firas Bannout prescribed most often to Medicare patients was Levetiracetam, with 537 prescriptions and refills. In total Firas Bannout wrote 4,083 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 537 | 897 | 98 | $35K |
| Lacosamide Generic | 412 | 523 | 64 | $42K |
| Lamotrigine Generic | 394 | 708 | 73 | $8,259 |
| Clonazepam Generic | 215 | 222 | 43 | $3,233 |
| Zonisamide Generic | 173 | 291 | 34 | $7,431 |
| Briviact Brivaracetam | 165 | 201 | 22 | $281K |
| Topiramate Generic | 146 | 258 | 29 | $3,593 |
| Divalproex Sodium Er Divalproex Sodium | 140 | 216 | 25 | $9,112 |
| Clobazam Generic | 124 | 141 | 21 | $32K |
| Divalproex Sodium Generic | 98 | 170 | 23 | $14K |
| Gabapentin Generic | 94 | 142 | 20 | $4,355 |
| Vimpat Lacosamide | 89 | 107 | Under 11 | $127K |
| Pregabalin Generic | 86 | 104 | 11 | $1,506 |
| Levetiracetam Er Levetiracetam | 84 | 166 | 18 | $4,739 |
| Oxcarbazepine Generic | 83 | 126 | 18 | $11K |
Brand drugs: 576 claims; generic drugs: 3,427 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Firas Bannout $214 ($214 in general payments such as food, travel and fees) from 2 companies. The largest payer was Neuropace, Inc. with $200.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.